Ginsenosides for the treatment of insulin resistance and diabetes: Therapeutic perspectives and mechanistic insights
Author:
Open Access
- 22 March 2024
- journal article
- review article
- Published by Elsevier in Journal of Ginseng Research
- Vol. 48 (3) , 276-285
Abstract
No abstract availableKeywords
Funding Information
- National Research Foundation of Korea
- Ministry of Science, ICT and Future Planning (NRF-2022R1C1C1006000, NRF-2022R1A5A2021216)
This publication has 109 references indexed in Scilit:
- Notoginsenoside Ft1 acts as a TGR5 agonist but FXR antagonist to alleviate high fat diet-induced obesity and insulin resistance in miceActa Pharmaceutica Sinica B, 2021
- The effect of Korean Red Ginseng on sarcopenia biomarkers in type 2 diabetes patientsArchives of Gerontology and Geriatrics, 2020
- Ginsenoside Rd Ameliorates High Fat Diet‐Induced Obesity by Enhancing Adaptive Thermogenesis in a cAMP‐Dependent MannerObesity, 2020
- Hyperinsulinemia in individuals with obesity: Role of insulin clearanceObesity, 2015
- Antioxidative, anti-inflammatory, and matrix metalloproteinase inhibitory activities of 20(S)-ginsenoside Rg3 in cultured mammalian cell linesMolecular Biology Reports, 2012
- Ginsenoside Rg1 Promotes Glucose Uptake Through Activated AMPK Pathway in Insulin‐resistant Muscle CellsPhytotherapy Research, 2011
- The antidiabetic effect of ginsenoside Rb2 via activation of AMPKArchives of Pharmacal Research, 2011
- Effect of ginsenosides Rg3 and Re on glucose transport in mature 3T3‐L1 adipocytesPhytotherapy Research, 2010
- The study of ginsenoside on PPARγ expression of mononuclear macrophage in type 2 diabetesMolecular Biology Reports, 2009
- Effects of ginsenosides Rg3 and Rh2 on the proliferation of prostate cancer cellsArchives of Pharmacal Research, 2004